Studies, such as one involving the Bifidobacterium longum RAPO strain, showcase promising avenues for inhibiting key mediators like interleukin-17 (IL-17) associated with autoimmune diseases like RA [26]. This evidence concerns the gene IL17A and rheumatoid arthritis.